Tirzepatide, a novel medication, is generating excitement as a potential treatment for individuals living with type 2 diabetes . Unlike traditional diabetes medications , it operates through a unique mechanism, targeting both glucagon-like peptide-1 and the GIP hormone receptors. Clinical trials